pipeline-analysis
Med pipeline analysis: enumerate a biotech/pharma company's drug/device assets by phase, indication, and next catalyst, with risk-adjusted value framing and cash-runway assessment. The core valuation lens for clinical-stage names.
agentii-ai · 已有 AI 审核记录
安装与使用
运行命令前先阅读来源与依赖说明。复制命令不会自动安装或执行。
npx skills add agentii-ai/agentii-investment-intelligence --skill pipeline-analysis技能说明
name: pipeline-analysis description: "Med pipeline analysis: enumerate a biotech/pharma company's drug/device assets by phase, indication, and next catalyst, with risk-adjusted value framing and cash-runway assessment. The core valuation lens for clinical-stage names." multi_ticker_semantics: single_target temporal_scope: default_quarters: 4 max_quarters: 8 description: "Catalyst window default 4 quarters; up to 8 for long-horizon pipeline mapping." allowed_tools:
- get_company_drugs
- get_company_devices
- search_universe_drugs
- search_universe_devices
- search_companies
- search_sec_filings
- search_documents
- read_source_outline
- read_source_pages
- search_xbrl_facts
- search_investment_cases
- get_investment_case
- search_investment_strategies
- get_investment_strategy
- search_by_analogue
- search_knowledge_entries
- get_knowledge_entry retrieval_scope: unstructured_document_search min_tool_diversity: 3 parameter_free: false
Methodology inspired by publicly taught pipeline-valuation frameworks; all text is an original paraphrase.
Defaults
| Parameter | Default Value | Rationale |
|---|---|---|
| asset_scope | all disclosed assets | Full-pipeline enumeration first |
| include_devices | true | Devices via PMA/De Novo share catalyst logic |
| valuation_frame | risk-adjusted | rNPV-style thinking, not raw NPV |
Preflight
Run canonical pre-flight per contracts/preflight.md. Propagate X-Agentii-Trace per contracts/x-agentii-trace-header.md.
Triggers
- "Analyze [biotech ticker]'s pipeline."
- "What's in [ticker]'s clinical portfolio?"
- "Map [ticker]'s assets by phase and indication."
- "What are [ticker]'s next catalysts?"
- "How much runway does [ticker] have?"
- "Risk-adjusted view of [ticker]'s pipeline value."
- "Which of [ticker]'s programs matter most?"
- "Pipeline deep-dive for [ticker]."
- "What devices does [ticker] have in the works?"
- "Compare [ticker]'s pipeline to its peers."
Production Grounding
- Enumerate assets from
get_company_drugs/get_company_devices(049 universes); supplement with filings (search_sec_filings,read_source_*) for trial phase/status. - Phase-aware valuation: discovery/preclinical minimal; P1/P2 option-value; P3/registered majority of risk-adjusted value. Apply AdCom-style scrutiny axes when sizing pivotal-stage assets (per
references/knowledge-frameworks.md). - Cash runway (quarters) gates which catalysts the company can reach; funding risk is pipeline risk.
Data Source Priority
get_company_drugs/get_company_devices— asset inventory from the 049 universes.search_sec_filings/read_source_*— phase, status, trial data, guidance.search_xbrl_facts— cash/R&D spend for runway.- Knowledge layer:
search_investment_strategies(sectors=med)+ cases for playbook grounding.
Methodology
Retrieval Scope
unstructured_document_search
Retrieval Strategy
- Pull asset inventory (
get_company_drugs/get_company_devices). - Enrich per-asset phase/status/next-catalyst from filings.
- Compute runway from balance-sheet facts.
- Size each asset risk-adjusted; ground in strategies/cases.
Temporal Scope
See frontmatter temporal_scope block.
Tool Allowlist
See frontmatter allowed_tools.
Protocol
- Asset enumeration
- Phase/status enrichment
- Runway assessment
- Risk-adjusted synthesis
Modes
- Full pipeline (default): all assets with catalysts.
- Value-drivers: only the top risk-adjusted assets.
- Runway-focused: funding-requirement analysis.
Tool Fallbacks
| Failure | Fallback |
|---|---|
| get_company_drugs empty | Reconstruct from filings keyword search; annotate coverage_gap |
| No cash data | Flag runway unavailable |
| Knowledge tools empty | Proceed with structured data only |
Output File
{ticker}/{YYYY-MM-DD_HHMM}_pipeline-analysis_{affix}.md
Output Structure
- Executive Summary — pipeline stance in 2-3 sentences
- Asset Table — phase, indication, next catalyst, risk-adjusted sizing
- Value Drivers — top assets with scrutiny-axes assessment
- Runway & Funding — quarters of cash, funding needs
- Historical Context — strategies/cases with /v/ citations
- Coverage Gaps — degraded flags
Error Handling
| Error | Fallback |
|---|---|
| Phase unknown | Mark "undisclosed"; do not guess |
| No catalysts found | Say so explicitly; note pipeline may be early-stage |
Memory Load
See contracts/memory-load.md.
Snapshot
See contracts/snapshot-synthesis.md.
Final Summary (TUI)
Include ### Key Citations block with 0-10 clickable /v/ URLs.
References
contracts/citation-and-memory.mdcontracts/output-frontmatter-schema.mdcontracts/memory-load.mdcontracts/snapshot-synthesis.mdcontracts/preflight.mdreferences/knowledge-frameworks.md